P39 Compared With Reference Omalizumab in Chronic Spontaneous Urticaria: Results From a Double-Blind, Randomized, ...

There are many different types of hives -- urticaria -- with many different causes. In most cases, these puffy, red, or skin-colored bumps and wheals appear suddenly due to an allergic reaction to ...

The mainstay of treatment for urticaria is oral antihistamines as they reduce itch, wheal duration and numbers. Management is better achieved by taking antihistamines daily, not just when the ...

The objective of this study was to evaluate the cost effectiveness of levocetirizine, a first-line treatment for urticaria. Methods: Data were collected from two placebo-controlled trials and from ...

THE cold weather can trigger a range of symptoms, with the most common being shivering. But if certain symptoms seem out of ...

Looking for reliable medications to treat 'Hives'? This page offers a detailed resource for the most up-to-date treatment options, including both generic and brand-name medications. For informed ...

Patients with chronic spontaneous urticaria experienced substantial reductions in hives and itch with briquilimab through 16 ...

Novartis is just months away from filing for approval of oral BTK inhibitor remibrutinib as a treatment for chronic spontaneous urticaria – also known as chronic hives – after reporting long ...

The duration of CU is also unpredictable and disease control is often suboptimal, especially when treatment is inadequate. Chronic urticaria has a significant impact on work, even when it is well ...

Sanofi and Regeneron have reported disappointing results in a trial of Dupixent in people with chronic spontaneous urticaria (CSU) who don't respond to the only approved biologic treatment ...

Analyst Silvan Tuerkcan of JMP Securities reiterated a Buy rating on Allakos (ALLK – Research Report), with a price target of $3.00.Stay Ahead ...